Rumela Chakrabarti, PhD of Penn Medicine @PennMedicine discusses tailoring revolutionary treatment for triple-negative breast cancer. _____________ Immunotherapies have revolutionized care for people with multiple cancers. But when offered to those with triple-negative breast cancer (TNBC), an particularly aggressive type of the disease, fewer than 20 percent respond. “A big question in the field has been, Why are the rest not responding?” says Rumela Chakrabarti, an assistant professor at Penn’s School of Veterinary Medicine. Chakrabarti and the colleagues illuminate the nature of the molecules at play. We identified a signaling mechanism that could be used for potential improved target therapies in…
Author: Editor
Paulo Rodriguez, PhD of Moffitt Cancer Center @MoffittNews explains immunosuppression in tumors overall in the study. ______________ An active immune system plays an important role in stopping the development of cancer by detecting and targeting the tumor cells for destruction. Some change in the immune system’s normal activities can lead to accelerated growth of tumors. Researchers at the Moffitt Cancer Center decided to find out how myeloid cells, a form of immune cell, may contribute to cancer progression. The Moffitt team explains how protein-signaling pathways associated with cellular stress processes turn myeloid cells into tumor-promoting players, and indicates that targeting…
Paulo Rodriguez, PhD of Moffitt Cancer Center @MoffittNews answers what the effects are in activation for identifying molecular pathways that control immunosuppression in tumors. ______________ An active immune system plays an important role in stopping the development of cancer by detecting and targeting the tumor cells for destruction. Some change in the immune system’s normal activities can lead to accelerated growth of tumors. Researchers at the Moffitt Cancer Center decided to find out how myeloid cells, a form of immune cell, may contribute to cancer progression. The Moffitt team explains how protein-signaling pathways associated with cellular stress processes turn myeloid…
Paulo Rodriguez, PhD of Moffitt Cancer Center @MoffittNews discusses identifying molecular pathways that control immunosuppression in tumors. ______________ An active immune system plays an important role in stopping the development of cancer by detecting and targeting the tumor cells for destruction. Some change in the immune system’s normal activities can lead to accelerated growth of tumors. Researchers at the Moffitt Cancer Center decided to find out how myeloid cells, a form of immune cell, may contribute to cancer progression. The Moffitt team explains how protein-signaling pathways associated with cellular stress processes turn myeloid cells into tumor-promoting players, and indicates that…
In this video series, presented in April of 2020, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and Dr. Ben Levy have a candid discussion regarding cancer and Covid 19. In this time of social distancing and limiting clinic exposure, the doctors sat down in their respective homes to discuss some of the questions we all hear regarding these unprecedented times, and how they effect primarily cancer patients. In this four part series, we discuss testing, ongoing cancer treatment, and many other issues relating to a cancer diagnosis in the middle of a pandemic. Part 1 – Should…
In this video series, presented in April of 2020, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and Dr. Ben Levy have a candid discussion regarding cancer and Covid 19. In this time of social distancing and limiting clinic exposure, the doctors sat down in their respective homes to discuss some of the questions we all hear regarding these unprecedented times, and how they effect primarily cancer patients. In this four part series, we discuss testing, ongoing cancer treatment, and many other issues relating to a cancer diagnosis in the middle of a pandemic. Part 1 – Should…
In this video series, presented in April of 2020, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and Dr. Ben Levy have a candid discussion regarding cancer and Covid 19. In this time of social distancing and limiting clinic exposure, the doctors sat down in their respective homes to discuss some of the questions we all hear regarding these unprecedented times, and how they effect primarily cancer patients. In this four part series, we discuss testing, ongoing cancer treatment, and many other issues relating to a cancer diagnosis in the middle of a pandemic. Part 1 – Should…
In this video series, presented in April of 2020, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and Dr. Ben Levy have a candid discussion regarding cancer and Covid 19. In this time of social distancing and limiting clinic exposure, the doctors sat down in their respective homes to discuss some of the questions we all hear regarding these unprecedented times, and how they effect primarily cancer patients. In this four part series, we discuss testing, ongoing cancer treatment, and many other issues relating to a cancer diagnosis in the middle of a pandemic. Part 1 – Should…
In April of 2020, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and Dr. Ben Levy had a candid discussion regarding telemedicine in the time of the current pandemic. In this time of social distancing and limiting clinic exposure, the sudden need for telemedicine and web consults is perhaps changing the future of medicine on a faster pace than we have previously thought possible. In this three part series the doctors discuss a wide range of topics surrounding the use of telemedicine and potential challenges for providers and patients alike. Does this new process create new helpful tools?…
In April of 2020, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and Dr. Ben Levy had a candid discussion regarding telemedicine in the time of the current pandemic. In this time of social distancing and limiting clinic exposure, the sudden need for telemedicine and web consults is perhaps changing the future of medicine on a faster pace than we have previously thought possible. In this three part series the doctors discuss a wide range of topics surrounding the use of telemedicine and potential challenges for providers and patients alike. Does this new process create new helpful tools?…
In April of 2020, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and Dr. Ben Levy had a candid discussion regarding telemedicine in the time of the current pandemic. In this time of social distancing and limiting clinic exposure, the sudden need for telemedicine and web consults is perhaps changing the future of medicine on a faster pace than we have previously thought possible. In this three part series the doctors discuss a wide range of topics surrounding the use of telemedicine and potential challenges for providers and patients alike. Does this new process create new helpful tools?…
In this video from our Cancer Basics series, Narjust Duma, MD, Assistant Professor and Thoracic Oncologist with the University of Wisconsin Carbone Cancer Center interviews Dr. Grace Blitzer, Radiation Oncology Resident with the Department of Human Oncology at the University of Wisconsin School of Medicine and Public Health. Dr. Blitzer shares with us a great description of what a CT Simulation Scan for Radiation Therapy is, how it is used, and why it is important for receiving radiation therapy. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Narjust Duma, MD, Assistant Professor and Thoracic Oncologist at the University of Wisconsin Carbone Cancer Center discusses COVID 19 and how it affects the community. The second video in this 2 part series, presented in Spanish for the Latino community, covers information relating to the following topics: What is coronavirus? What are the common symptoms? How is it contracted, and how can it be prevented? Who is at risk, and are people with cancer at higher risk? Does the risk of exposure change my treatment for cancer? What happens if I get coronavirus and have cancer? I hear about treatments:…
Narjust Duma, MD, Assistant Professor and Thoracic Oncologist at the University of Wisconsin Carbone Cancer Center discusses COVID 19 and how it affects the community. This 2 part series, presented in Spanish for the Latino community, covers information relating to the following topics: What is coronavirus? What are the common symptoms? How is it contracted, and how can it be prevented? Who is at risk, and are people with cancer at higher risk? Does the risk of exposure change my treatment for cancer? What happens if I get coronavirus and have cancer? I hear about treatments: are these now established…
In partnership with Clinical Care Options, GRACE President Jack West, MD provides information regarding immunotherapy for advanced NSCLC, and discussing goals and treatments with your health care providers.For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Narjust Duma, MD, Assistant Professor and Thoracic Oncologist at the University of Wisconsin Carbone Cancer Center interviews Julia Maues, breast cancer patient and advocate, and founder of https://www.itsnot.pink/.In this interview, Dr. Duma interviews Julia about her journey as a cancer patient and becoming an advocate. This interview is done in Portuguese, for our global community. For more information (in english) about Julia’s journey, please visit https://www.itsnot.pink/my-story.For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Narjust Duma, MD, Assistant Professor and Thoracic Oncologist at the University of Wisconsin Carbone Cancer Center interviews Juanita Segura, lung cancer patient and advocate. In this series Juanita shares her inspiring story from diagnosis to today, showing how her positivity and optimism powers her through. In this third and final video Juanita shares with us her message – she is still living.For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Narjust Duma, MD, Assistant Professor and Thoracic Oncologist at the University of Wisconsin Carbone Cancer Center interviews Juanita Segura, lung cancer patient and advocate. In this series Juanita shares her inspiring story from diagnosis to today, showing how her positivity and optimism powers her through. In this second video Juanita discusses her treatment journey.For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Narjust Duma, MD, Assistant Professor and Thoracic Oncologist at the University of Wisconsin Carbone Cancer Center interviews Juanita Segura, lung cancer patient and advocate. In this series Juanita shares her inspiring story from diagnosis to today, showing how her positivity and optimism powers her through.For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach.Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center.Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California.In this series, the doctors discuss a series of cases related to EGFR Mutations. In an EGFR mutation with MET amplification, what are treatment decisions and what is the importance of the level of MET amplification?For more, please visit http://cancerGRACE.org/. To join…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach.Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center.Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California.In this series, the doctors discuss a series of cases related to EGFR Mutations. For EGFR mutations treated with Tagrisso, and with progression while on treatment, what is the role of repeat biopsy?For more, please visit http://cancerGRACE.org/. To join the conversation, visit…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach.Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center.Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California.In this series, the doctors discuss a series of cases related to EGFR Mutations. For EGFR mutations and the FLAURA trial, is there a difference in data based on demographics and how can that effect treatment decisions?For more, please visit http://cancerGRACE.org/. To…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach. Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center. Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California. In this series, the doctors discuss a series of cases related to EGFR mutations, patient progression and next steps. Is there a place for chemo and the inclusion of immunotherapy? Where does immunotherapy fit in to the mix? For…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach. Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center. Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California. In this series, the doctors discuss a series of cases related to EGFR Mutation with high PDL-1 – does immunotherapy have a role in treatment? For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach.Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center.Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California.In this series, the doctors discuss a series of cases related to EGFR mutations and what is the recommended treatment for common EGFR mutations.For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach. Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center. Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California. In this series, the doctors discuss a series of cases related to EGFR Mutations – is there a place for chemotherapy and an EGFR inhibitor concurrently or sequentially in treatment decisions? For more, please visit http://cancerGRACE.org/. To join the…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach. Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center. Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California. In this series, the doctors discuss a series of cases related to EGFR Mutations – is there a place for chemotherapy and an EGFR inhibitor concurrently or sequentially in treatment decisions? For more, please visit http://cancerGRACE.org/. To join the…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach.Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center.Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California.In this series, the doctors discuss a series of cases related to an EGFR mutation. In this video, the discussion is regarding uncommon EXON 20 mutation, suggested treatments, targeted therapy and clinical trials.For more, please visit http://cancerGRACE.org/. To join the conversation, visit…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda.Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center.Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center.The doctors discuss a series of cases related to a diagnosis of NSCLC. In this video, the discussion is regarding a patient with a HER2 mutation, what is the clinical significance, and how does a positive HER2 mutation effect treatment decisions?For more, please visit http://cancerGRACE.org/. To join…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda. Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center. Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center. The doctors discuss a series of cases related to a diagnosis of ALK Positive NSCLC. In this video, the discussion is regarding a patient with ALK positive and high PDL-1. What is the first line treatment for potentially competing targets? For more, please visit…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda.Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center.Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center.The doctors discuss a series of cases related to a diagnosis of ALK Positive NSCLC. In this video, they discuss progression after success on Alk inhibitors, and if there is a role for combination therapies like chemo/radiation and immunotherapy.For more, please visit http://cancerGRACE.org/. To join the conversation,…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda. Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center. Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center. The doctors discuss a series of cases related to a diagnosis of ALK Positive NSCLC. In this video, the discussion is regarding progression after success on an ALK inhibitor. Do you continue the ALK inhibitor when transitioning to a chemo based treatment? For more,…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda. Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center. Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center. The doctors discuss a series of cases related to a diagnosis of ALK Positive NSCLC. In this video, they discuss developing resistance to Alk inhibitors, treatment approaches and biopsies, and what are the next steps. For more, please visit http://cancerGRACE.org/. To join the conversation,…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda. Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center. Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center. The doctors discuss a series of cases related to a diagnosis of ALK Positive NSCLC. In this video, they discuss developing resistance to Alk inhibitors, treatment approaches and biopsies, and what are the next steps. For more, please visit http://cancerGRACE.org/. To join the conversation,…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda. Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center. Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center. The doctors discuss a series of cases related to a diagnosis of ALK Positive NSCLC. In this video, the discussion is regarding a patient with ALK positive asymptomatic brain metastases. Is the standard approach of focal radiation before beginning ALK inhibitor appropriate, or do…
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda. Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center. Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center. The doctors discuss a series of cases related to a diagnosis of ALK Positive NSCLC. In this video, the discussion is surrounding what the approach for first line treatment would be for a patient with good performance status, lung adenocarcinoma, metastatic disease and adrenal…
Terapias para el Cancer: Conocimientos Basicos (Cancer Therapy – Basics) ¿Que es oncologia geriátrica? What is Geriatric Oncology? Narjust (N.J.) Duma, MD, Assistant Professor And Thoracic Oncologist with the University of Wisconsin Carbone Cancer Center Provides us with more information for our Latino community. In this video Dr. Duma speaks with Enrique Soto Pérez de Celis, MD, a Medical Oncologist / Oncólogo Médico with the Department of Geriatrics / OncologÃa Geriátrica at the Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico. In this spanish language video Dr. Duma and Dr. Soto discuss geriatric oncology. For more,…
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC . Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis. Dr. Matthew Gubens is a thoracic oncologist who treats patients with lung cancer, mesothelioma and other thoracic malignancies, including thymoma and thymic carcinoma,…
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC . Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis. Dr. Matthew Gubens is a thoracic oncologist who treats patients with lung cancer, mesothelioma and other thoracic malignancies, including thymoma and thymic carcinoma,…
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC . Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis. Dr. Matthew Gubens is a thoracic oncologist who treats patients with lung cancer, mesothelioma and other thoracic malignancies, including thymoma and thymic carcinoma,…
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC . Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis. Dr. Matthew Gubens is a thoracic oncologist who treats patients with lung cancer, mesothelioma and other thoracic malignancies, including thymoma and thymic carcinoma,…
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC . Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis. Dr. Matthew Gubens is a thoracic oncologist who treats patients with lung cancer, mesothelioma and other thoracic malignancies, including thymoma and thymic carcinoma,…
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC . Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis. Dr. Matthew Gubens is a thoracic oncologist who treats patients with lung cancer, mesothelioma and other thoracic malignancies, including thymoma and thymic carcinoma,…
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC . Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis. Dr. Matthew Gubens is a thoracic oncologist who treats patients with lung cancer, mesothelioma and other thoracic malignancies, including thymoma and thymic carcinoma,…
Earn CME: https://www.naccme.com/program/7335-2 In this webcast from the ‘MRD in Hematologic Malignancies: Testing Considerations and Challenges’ symposium, Dr. Gail J. Roboz and the symposium faculty discuss a series of cases that demonstrate the use of MRD testing in the treatment of hematologic malignancies. © 2019 Imedex, an HMP Company
Earn CME: https://www.naccme.com/program/7335-2 In this webcast from the ‘MRD in Hematologic Malignancies: Testing Considerations and Challenges’ symposium, Dr. Ajay Chari discusses the role of MRD in the treatment of multiple myeloma. © 2019 Imedex, an HMP Company
Earn CME: https://www.naccme.com/program/7335-2 In this webcast from the ‘MRD in Hematologic Malignancies: Testing Considerations and Challenges’ symposium, Dr. Steven E. Coutre discusses the role of MRD testing in the treatment of chronic lymphocytic leukemia (CLL). © 2019 Imedex, an HMP Company
Earn CME: https://www.naccme.com/program/7335-2 In this webcast from the ‘MRD in Hematologic Malignancies: Testing Considerations and Challenges’ symposium, Dr. Gail J. Roboz discusses the role of minimal residual disease (MRD) testing in the treatment of acute myeloid leukemia (AML). © 2019 Imedex, an HMP Company
Earn CME: https://www.naccme.com/program/7335-2 In this webcast from the ‘MRD in Hematologic Malignancies: Testing Considerations and Challenges’ symposium, Dr. Aaron C. Logan discusses the latest treatment guidelines for acute lymphocytic leukemia (ALL). © 2019 Imedex, an HMP Company
Earn CME: https://www.naccme.com/program/7335-2 In this webcast from the ‘MRD in Hematologic Malignancies: Testing Considerations and Challenges’ symposium, Dr. Prashant Kapoor provides an overview of the game-changing potential that MRD has in the treatment of hematologic malignancies. © 2019 Imedex, an HMP Company